Trials / Recruiting
RecruitingNCT05564273
Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions
Testing the Efficacy of Viome-designed Condition-based Supplements and Viome Precision Supplements to Improve Clinical Outcomes for Metabolic Conditions
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Viome · Industry
- Sex
- All
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
US residents who have obesity and sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will not utilize clinical sites.
Detailed description
Participants who meet the eligibility criteria are randomized into any of the three arms including: the placebo arm, VIOME's condition-based supplements (VCS) arm or the VIOME Precision Nutrition Program (VPNP) arm. Placebo, Viome-designed condition-based supplements and Viome's Precision Nutrition Program include supplements and/or dietary recommendations towards improving the symptoms associated with metabolic wellness. The trial will last approximately 4 months for each participant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | VIOME Precision Nutrition Program | Precision supplement based on the participants microbiome sample results. Participants in this arm may receive supplements, diet recommendations, and app coaching. |
| DIETARY_SUPPLEMENT | VIOME-designed condition-based supplements | Pre-formulated supplements based on overall health conditions. Participants in this arm may receive supplements, diet recommendations, and app coaching. |
Timeline
- Start date
- 2023-10-13
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2022-10-03
- Last updated
- 2025-01-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05564273. Inclusion in this directory is not an endorsement.